\ BIP! Finder for COVID-19 - Impact-based ranking
Open dataset
Publication

BIP! Finder for COVID-19

Statistics
@BipFinder

This version of BIP! Finder aims to ease the exploration of COVID-19-related literature by enabling ranking articles based on various impact metrics.

Last Update: 18 - 01 - 2023 (628506 entries)

Provided impact measures:
Popularity: Citation-based measure reflecting the current impact.
Influence: Citation-based measure reflecting the total impact.
Reader Attention: The current number of Mendeley readers.
Social Media Attention: The number of recent tweets related to this article.
*More details on these impact measures can be found here.
Score interpretations:
Exceptional score (in top 0.01%).
Substantial score (in top 1%).
Average score (in bottom 99%).
Score not available.
Main data sources:
CORD-19 dataset(1) (list of papers)
LitCovid hub(2) (list of papers)
PMC & PubMed (citations)
Mendeley (number of readers)
COVID-19-TweetIDs(3) (tweets)

Use:  Impact  Relevance & Impact

Rank by:
Popularity Influence Reader Attention Social Media Attention

<< 68 69 70 71 72 >>

TitleVenueYearImpactSource
3451Methylprednisolone: Pseudomonas aeruginosa lung abscess: case report  

N/A2022       CORD-19
3452Bamlanivimab/immunosuppressants: Headache/fatigue following off-label treatment and Coronavirus disease-2019: 18 case reports  

N/A2022       CORD-19
3453AZD-1222: Tumefactive demyelinating brain lesion: case report  

N/A2022       CORD-19
3454Indapamide/potassium: Hypokalaemia and lack of efficacy: case report  

N/A2022       CORD-19
3455Atropine/dopamine: Lack of efficacy: case report  

N/A2022       CORD-19
3456COVID-19-Vaccine-Pfizer-BioNTech: Double-seronegative myasthenia gravis: case report  

N/A2022       CORD-19
3457Multiple drugs: Elevated INR and off-label use: case report  

N/A2022       CORD-19
3458Immunosuppressants and antiviral: COVID-19 and lack of efficacy: case report  

N/A2022       CORD-19
3459Multiple drugs: Lack of efficacy following off-label use: case report  

N/A2022       CORD-19
3460Pre-COVID-19 psychotropic medication use linked to higher rate of dementia  

N/A2022       CORD-19
3461Mycophenolate-mofetil/tacrolimus/prednisone: Adenovirus-mediated hepatitis: case report  

N/A2022       CORD-19
3462Dexamethasone/metoprolol-succinate/remdesivir: Sinus bradycardia following drug interaction and off label use: case report  

N/A2022       CORD-19
3463Remdesivir: Sinus bradycardia: case report  

N/A2022       CORD-19
3464Underactive and low compliance bladder: A possible Presentation of COVID-19 vaccination  

Vaccine-related adverse events have been increasingly reported as the COVID-19 vaccination campaign progresses worldwide. Urological symptoms after COVID-19 vaccination are reported rarely. Herein, we report a case of urinary retention following the second dose of Oxford/AstraZeneca COVID-19 vaccine injection.

N/A2022       CORD-19
3465Remdesivir does not increase risk of AKI or ALI in COVID-19 patients  

N/A2022       CORD-19
3466Elasomeran: Recurrence of myopericarditis: case report  

N/A2022       CORD-19
3467Prednisolone/tozinameran: Acquired haemophilia and COVID-19 pneumoniae: case report  

N/A2022       CORD-19
3468Multiple drugs: Lack of efficacy: case report  

N/A2022       CORD-19
3469Testing for asymmetric non-linear short- and long-run relationships between crypto-currencies and stock markets  

Using the NARDL model for the period of pandemic COVID19, we examined the asymmetric relationship between six crypto-currencies (Bitcoin, Litecoin, Bitcoin gold, Dash, Maker, and Ehereum) and seven stock market prices (S&P500, CAC40, DAX30, NIKKEI, FTSE, FTSEMIB, and SPTSX) accounting for the effects of Gold and WTI prices. In the long run, our results revealed, in most cases, a positive asymmetric relationship between digital and financial assets, suggesting a weak safe haven role for crypto-currencies. The oil price (WTI) was also found to act as a diversifier. However, for, the results revealed, in most cases, a negative asymmetric relationship between the yellow metal and the different stock prices, suggesting that gold can act as a good hedging instrument or a safe haven against stock prices in the long run. On the other hand, in the short run, the results indicate that only Bitcoin, Litecoin, and Maker have an asymmetric effect on the chosen stock prices but the effect is positive in most cases. Moreover, gold can act as a hedge/safe-haven asset in the short run. Finally, while examining the dynamic response of stock prices to the negative and positive shocks of crypto-currencies, we concluded that the majority of stock prices respond more to the negative shocks of crypto-currencies than to the positive ones.

N/A2022       CORD-19
3470COVID-19 vaccine-Pfizer-BioNTech/methylprednisolone aceponate: Subacute cutaneous lupus erythematosus and lack of efficacy: case report  

N/A2022       CORD-19
3471Nivolumab: Acute eosinophilic pneumonia: case report  

N/A2022       CORD-19
3472Non-serious case reports  

N/A2022       CORD-19
3473COVID-19-vaccine: Myocardial infarction due to aggravation of antiphospholipid syndrome: case report  

N/A2022       CORD-19
3474Hydroxychloroquine: QT interval prolongation following off-label use: case report  

N/A2022       CORD-19
3475Tozinameran: Mild generalised malaise and systemic capillary leak syndrome: case report  

N/A2022       CORD-19
3476Betahistine/covid-19-vaccine-pfizer-biontech: Sudden sensorineural hearing loss and lack of efficacy: case report  

N/A2022       CORD-19
3477Abgeschlagenheit mit rechtsseitiger Lähmung und Sprachstörung 2 Wochen nach SARS-CoV-2-Infektion  

N/A2022       CORD-19
3478Elasomeran: Myopericarditis: case report  

N/A2022       CORD-19
3479Elasomeran: Myopericarditis: case report  

N/A2022       CORD-19
3480Tozinameran: Myocarditis: case report  

N/A2022       CORD-19
3481Dexamethasone/remdesivir/tocilizumab: Various toxicities: case report  

N/A2022       CORD-19
3482Multiple drugs: Bone necrosis, candida infection and lack of efficacy: 4 case reports  

N/A2022       CORD-19
3483Tozinameran: Myocarditis with QTc prolongation: case report  

N/A2022       CORD-19
3484SARS CoV-2 vaccine inactivated sinovac biotech: Vogt Koyanagi-Harada like panuveitis: case report  

N/A2022       CORD-19
3485Azd-1222: Ventricular tachycardia: case report  

N/A2022       CORD-19
3486AZD-1222: Vaccine induced thrombotic thrombocytopenia: 2 case reports  

N/A2022       CORD-19
3487Multiple drugs: Various toxicities: case report  

N/A2022       CORD-19
3488Prednisone: Hepatitis-B reactivation: case report  

N/A2022       CORD-19
3489Multiple drugs: COVID-19-associated cytokine storm, off-label use and lack of efficacy: case report  

N/A2022       CORD-19
3490AZD-1222: Disseminated intravascular coagulation-like syndrome: case report  

N/A2022       CORD-19
3491Dasatinib: Aggravation of bilateral pleural effusion: case report  

N/A2022       CORD-19
3492Avacopan/methylprednisolone/prednisone: Various toxicities: 8 case reports  

N/A2022       CORD-19
3493BBV-152: Myocarditis and myositis: case report  

N/A2022       CORD-19
3494Tozinameran: Scleroderma renal crisis: case report  

N/A2022       CORD-19
3495Lamotrigine: Haemophagocytic lymphohistiocytosis: case report  

N/A2022       CORD-19
3496Hydroxychloroquine/lopinavir/ritonavir: Second-degree atrioventricular block (Mobitz II) with left bundle branch block and paroxysmal atrial fibrillation with bradycardia following off label use: case report  

N/A2022       CORD-19
3497COVID-19-Vaccine-Pfizer-BioNTech: Myocarditis: case report  

N/A2022       CORD-19
3498Hydrogen-rich water alleviates inflammation and fatigue in COVID-19: A pilot study  

N/A2022       CORD-19
3499AZD-1222: Immune thrombotic thrombocytopenia and cerebral sinus venous thrombosis: 2 case reports  

N/A2022       CORD-19
3500AZD-1222: Lupus nephritis: case report  

N/A2022       CORD-19

<< 68 69 70 71 72 >>

(1) COVID-19 Open Research Dataset (CORD-19). 2020. Version 2022-06-02. Retrieved from https://ai2-semanticscholar-cord-19.s3-us-west-2.amazonaws.com/historical_releases.html. Accessed 2022-06-05. doi:10.5281/zenodo.3715506
(2) Chen Q, Allot A, & Lu Z. (2020) Keep up with the latest coronavirus research, Nature 579:193 and Chen Q, Allot A, Lu Z. LitCovid: an open database of COVID-19 literature. Nucleic Acids Research. 2020. (version 2023-01-10)
(3) Currently tweets of June 23rd to June 29th 2022 have been considered.

Copyright ATHENA RC 2020, Developed by: Thanasis Vergoulis, Ilias Kanellos, Serafeim Chatzopoulos, and Danae Pla Karidi
This service is provided "as is", without any warranties of any kind.
We have placed cookies on your device to help make this website and the services we offer better. By using this site, you agree to the use of cookies. Learn more
I accept